featured
Efficacy and Safety of the Oral PCSK9 Inhibitor MK-0616
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American College of Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of the oral PCSK9 inhibitor MK-0616: a phase 2b randomized controlled trial
J Am Coll Cardiol 2023 Feb 16;[EPub Ahead of Print], CM Ballantyne, P Banka, G Mendez, R Garcia, J Rosenstock, A Rodgers, G Mendizabal, Y Mitchel, AL CatapanoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.